See also this year's filing and all EDGAR filings for this company.
PDF Report 0001205922_2023_Vaccinex_INC.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'ComprehensiveIncomeNetOfTax'} |
Graph
Absolute values for 0001205922, Vaccinex INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,478,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 189,000 |
| 3 | remainder_Assets | 310,000 |
| 4 | LiabilitiesCurrent | 2,537,000 |
| 5 | LiabilitiesNoncurrent | 247,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,185,705 |
| 9 | ResearchAndDevelopmentExpense | 13,331,331 |
| 10 | remainder_Expenses | 382,376 |
| 11 | remainder_Revenues | 550,324 |
| 12 | remainder_NetIncome | 330,813 |
| 13 | remainder_ComprehensiveNetIncome | -19,815,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,977,000 |
| 1 | Liabilities | 2,784,000 |
| 2 | Expenses | 19,899,412 |
| 3 | Revenues | 550,324 |
| 4 | StockholdersEquity | 5,193,000 |
| 5 | NetIncome | -19,018,275 |
| 6 | ComprehensiveNetIncome | -28,925,775 |
| 7 | BaseVar | 25,678,274 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.27 |
| 9 | EconomicCapitalRatio | 0.599 |